American Century Companies’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-70,851
Closed -$1.77M – 3011
2026
Q1
$1.77M Buy
70,851
+12,019
+20% +$284K ﹤0.01% 2165
2025
Q4
$1.55M Buy
58,832
+7,816
+15% +$170K ﹤0.01% 2177
2025
Q3
$871K Buy
51,016
+19,869
+64% +$284K ﹤0.01% 2343
2025
Q2
$391K Hold
31,147
– – ﹤0.01% 2597
2025
Q1
$371K Sell
31,147
-8,795
-22% -$120K ﹤0.01% 2615
2024
Q4
$585K Buy
+39,942
New +$559K ﹤0.01% 2443
2022
Q1
– Sell
-140,548
Closed -$2.3M – 2366
2021
Q4
$2.3M Hold
140,548
– – ﹤0.01% 1305
2021
Q3
$4.08M Hold
140,548
– – ﹤0.01% 1081
2021
Q2
$4.88M Sell
140,548
-79,456
-36% -$2.52M ﹤0.01% 999
2021
Q1
$6.95M Buy
220,004
+660
+0.3% +$26.8K 0.01% 860
2020
Q4
$10.4M Buy
219,344
+12
+0% +$557 0.01% 757
2020
Q3
$10.2M Buy
+219,332
New +$7.53M 0.01% 709

Other funds holding ZYME

American Century Companies's ZYME Position: Q2 2026 in Review

American Century Companies sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 70,851 shares — an estimated $1.77M sold.

American Century Companies first reported a position in ZYME in Q3 2020 and held it in 12 quarters. The position peaked at $10.4M in Q4 2020. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • American Century Companies reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 70,851 Zymeworks shares in Q2 2026, an estimated $1.77M.
  • American Century Companies first reported a position in Zymeworks in Q3 2020 and held it in 12 quarters.
  • American Century Companies's Zymeworks position peaked at $10.4M in Q4 2020.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.